News

Filter

Current filters:

USAOphthalmicsPatents

1 to 9 of 96134 results

Denovo Biopharma acquires Lilly’s enzastaurin for development as a personalized medicine

Denovo Biopharma acquires Lilly’s enzastaurin for development as a personalized medicine

17-09-2014

Privately-held San Diego, USA-based biotech firm Denovo Biopharma has acquired enzastaurin, a late-stage…

BiotechnologyDenovo BiopharmaEli LillyenzastaurinGlobalLicensingOncology

Political developments impacting medicines for Russia

Political developments impacting medicines for Russia

17-09-2014

Russia's pharmaceutical market has been growing faster over recent years. The Pharma 2020 Strategy provides…

Markets & MarketingPharmaceuticalPoliticsRussia

Rheumatoid arthritis drug market will grow to $18.2 billion in 2023, report

17-09-2014

The rheumatoid arthritis (RA) disease-modifying antirheumatic drug market will increase from $14 billion…

Anti-Arthritics/RheumaticsbaricitinibBiosimilarsEli LillyEuropeIncyteJapanMarkets & MarketingPfizerPharmaceuticalUSAVertexXeljanz

First therapy under UK’s early access scheme to be Northwest Biotherapeutics’ DCVax-L

First therapy under UK’s early access scheme to be Northwest Biotherapeutics’ DCVax-L

17-09-2014

The UK’s Department of Health announced that DCVax-L, the dendritic cell-based vaccine from US company…

BiotechnologyDCVaxNorthwest BiotherapeuticsOncologyRegulationUK

Merck Serono to partner with Lupin for emerging market exposure

Merck Serono to partner with Lupin for emerging market exposure

17-09-2014

Merck Serono, the biotech unit of Germany’s Merck KGaA, has entered a strategic partnership with Indian…

Antibiotics and Infectious diseasesBiotechnologyCardio-vascularDiabetesGermanyIndiaLicensingLupinMerck KGaAMerck Serono

FDA approves AstraZeneca’s Movantik for opioid-induced constipation

FDA approves AstraZeneca’s Movantik for opioid-induced constipation

17-09-2014

The US Food and Drug Administration yesterday approved Movantik (naloxegol), an oral treatment for opioid-induced…

AstraZenecaGastro-intestinalsMovantikNektar TherapeuticsPharmaceuticalRegulationUSA

Endo offers to buy Auxilium Pharmaceuticals for $2.2 billion

Endo offers to buy Auxilium Pharmaceuticals for $2.2 billion

17-09-2014

Ireland-domiciled pain drugmaker Endo International has delivered an unsolicited proposal to acquire…

Auxilium PharmaceuticalsEndo InternationalMergers & AcquisitionsNeurologicalPharmaceuticalQLTWomen's HealthXiaflex

Indian pharma envisages exports expansion, including in Latin American

Indian pharma envisages exports expansion, including in Latin American

16-09-2014

India Brand Equity Foundation (IBEF) today announced the sustained collective efforts being made by the…

FinancialGenericsIndiaMarkets & MarketingPatentsSouth America

1 to 9 of 96134 results

Back to top